Fjarde AP Fonden Fourth Swedish National Pension Fund Boosts Position in The Clorox Company $CLX

Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in The Clorox Company (NYSE:CLX) by 73.2% during the 1st quarter, Holdings Channel reports. The firm owned 23,430 shares of the company’s stock after acquiring an additional 9,900 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Clorox were worth $2,428,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Vermillion & White Wealth Management Group LLC acquired a new stake in Clorox during the 3rd quarter valued at $25,000. Caitlin John LLC lifted its position in shares of Clorox by 1,807.1% in the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after acquiring an additional 253 shares in the last quarter. Darwin Wealth Management LLC acquired a new stake in shares of Clorox during the second quarter valued at $29,000. Vision Financial Markets LLC increased its position in Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares in the last quarter. Finally, Root Financial Partners LLC raised its stake in Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after purchasing an additional 145 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Trading Up 0.0%

CLX opened at $97.28 on Tuesday. The firm’s 50 day moving average is $94.22 and its 200-day moving average is $104.24. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The firm has a market capitalization of $11.76 billion, a P/E ratio of 15.79, a P/E/G ratio of 0.46 and a beta of 0.54.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s quarterly revenue was up .1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts expect that The Clorox Company will post 5.61 EPS for the current fiscal year.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CLX. The Goldman Sachs Group reaffirmed a “sell” rating and set a $83.00 price target on shares of Clorox in a research note on Friday, May 1st. Weiss Ratings upgraded shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. JPMorgan Chase & Co. cut their price target on Clorox from $99.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, May 1st. UBS Group reduced their target price on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Finally, Jefferies Financial Group cut their price objective on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company’s stock. According to MarketBeat, Clorox has an average rating of “Reduce” and a consensus target price of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.